• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Dec 1, 1997; 100(11): 2641–2647.
PMCID: PMC508465

Neural-immune interactions in health and disease.

Full Text

The Full Text of this article is available as a PDF (560K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aloisi F, Penna G, Cerase J, Menéndez Iglesias B, Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol. 1997 Aug 15;159(4):1604–1612. [PubMed]
  • Du X, Everett ET, Wang G, Lee WH, Yang Z, Williams DA. Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J Cell Physiol. 1996 Aug;168(2):362–372. [PubMed]
  • Ericsson A, Liu C, Hart RP, Sawchenko PE. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol. 1995 Oct 30;361(4):681–698. [PubMed]
  • Lee YB, Satoh J, Walker DG, Kim SU. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport. 1996 Apr 10;7(5):1062–1066. [PubMed]
  • Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang CS, Hobbs MV, Bloom FE, Campbell IL. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J Immunol. 1997 Aug 1;159(3):1344–1351. [PubMed]
  • Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int. 1996 Jul;29(1):55–64. [PubMed]
  • Sei Y, Vitković L, Yokoyama MM. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation. 1995 May-Jun;2(3):121–133. [PubMed]
  • Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J Neurochem. 1992 Feb;58(2):454–460. [PubMed]
  • Lipton SA. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat Med. 1997 Jan;3(1):20–22. [PubMed]
  • de Luca A, Weller M, Frei K, Fontana A. Maturation-dependent modulation of apoptosis in cultured cerebellar granule neurons by cytokines and neurotrophins. Eur J Neurosci. 1996 Sep;8(9):1994–2005. [PubMed]
  • Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest. 1997 Dec 1;100(11):2648–2652. [PMC free article] [PubMed]
  • Campbell IL. Neuropathogenic actions of cytokines assessed in transgenic mice. Int J Dev Neurosci. 1995 Jun-Jul;13(3-4):275–284. [PubMed]
  • Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology. 1995 Aug;45(8):1561–1569. [PubMed]
  • Banks WA, Kastin AJ. Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays. J Neuroimmunol. 1997 Oct;79(1):22–28. [PubMed]
  • Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57(11):1011–1026. [PubMed]
  • Layé S, Bluthé RM, Kent S, Combe C, Médina C, Parnet P, Kelley K, Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol. 1995 May;268(5 Pt 2):R1327–R1331. [PubMed]
  • Wong ML, Rettori V, al-Shekhlee A, Bongiorno PB, Canteros G, McCann SM, Gold PW, Licinio J. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med. 1996 May;2(5):581–584. [PubMed]
  • DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab. 1997 Jul;82(7):2182–2191. [PubMed]
  • Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol. 1995 Apr;9(4):401–412. [PubMed]
  • Grota LJ, Bienen T, Felten DL. Corticosterone responses of adult Lewis and Fischer rats. J Neuroimmunol. 1997 Apr;74(1-2):95–101. [PubMed]
  • Madden KS, Moynihan JA, Brenner GJ, Felten SY, Felten DL, Livnat S. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol. 1994 Jan;49(1-2):77–87. [PubMed]
  • Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 1991 Oct 18;254(5030):421–423. [PubMed]
  • Payan DG. Neuropeptides and inflammation: the role of substance P. Annu Rev Med. 1989;40:341–352. [PubMed]
  • Brenneman DE, Hill JM, Glazner GW, Gozes I, Phillips TW. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int J Dev Neurosci. 1995 Jun-Jul;13(3-4):187–200. [PubMed]
  • Sternberg EM, Young WS, 3rd, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4771–4775. [PMC free article] [PubMed]
  • Misiewicz B, Poltorak M, Raybourne RB, Gomez M, Listwak S, Sternberg EM. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp Neurol. 1997 Aug;146(2):305–314. [PubMed]
  • Goldstein DS, Garty M, Bagdy G, Szemeredi K, Sternberg EM, Listwak S, Pacak K, Deka-Starosta A, Hoffman A, Chang PC, et al. Role of CRH in glucopenia-induced adrenomedullary activation in rats. J Neuroendocrinol. 1993 Oct;5(5):475–486. [PubMed]
  • Zelazowski P, Patchev VK, Zelazowska EB, Chrousos GP, Gold PW, Sternberg EM. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease. Brain Res. 1993 Dec 17;631(1):22–26. [PubMed]
  • Schmidt ED, Janszen AW, Wouterlood FG, Tilders FJ. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J Neurosci. 1995 Nov;15(11):7417–7426. [PubMed]
  • Remmers EF, Longman RE, Du Y, O'Hare A, Cannon GW, Griffiths MM, Wilder RL. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet. 1996 Sep;14(1):82–85. [PubMed]
  • Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996 Oct 31;383(6603):787–793. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...